CLINICAL CHARACTERISTICS OF STATIN MANAGEMENT IN A COHORT WITH CARDIOVASCULAR RISK IN COLOMBIA

被引：0

作者：

Aldana, V ^{[1
]}

Vera, C. C. ^{[1
]}

Jimenez, A. ^{[1
]}

Horta, P. ^{[1
]}

Carrasquilla, M. ^{[2
]}

Salcedo Mejia, F. ^{[2
]}

Alvis Zakzuk, N. J. ^{[3
]}

Moyano, L. ^{[2
]}

Londono, S. ^{[4
]}

Moreno, J. P. ^{[4
]}

Botero, L. ^{[4
]}

机构：

[1] Inst Cardiovasc Tolima, Ibague, Colombia

[2] ALZAK Fdn, Cartagena, Colombia

[3] Univ Costa, Bogota, Colombia

[4] Sanofi, Bogota, Colombia

来源：

VALUE IN HEALTH | 2023年 / 26卷 / 06期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

CO188

引用

页码：S50 / S50

页数：1

共 50 条

[21] Statin therapy in individuals with intermediate cardiovascular risk
Kim, Joongmin
Kim, Hyeongsoo
Park, Sang Hyun
Kang, Yura
Han, Kyungdo
Lee, Sang-Hak
METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 150
[22] Cardiovascular Risk and Statin Use in the United States
Johansen, Michael Edward
Green, Lee A.
Sen, Ananda
Kircher, Sheetal
Richardson, Caroline R.
ANNALS OF FAMILY MEDICINE, 2014, 12 (03) : 215 - 223
[23] Statin combination therapy and cardiovascular risk reduction
Toth, Peter P.
Farnier, Michel
Tomassini, Joanne E.
Foody, JoAnne M.
Tershakovec, Andrew M.
FUTURE CARDIOLOGY, 2016, 12 (03) : 289 - 315
[24] STATIN THERAPY IN INDIVIDUALS WITH INTERMEDIATE CARDIOVASCULAR RISK
Lee, S. -H.
ATHEROSCLEROSIS, 2023, 379 : S168 - S168
[25] Cardiovascular Risk and Statin Therapy Considerations in Women
Gheorghe, Gina
Toth, Peter P.
Bungau, Simona
Behl, Tapan
Ilie, Madalina
Stoian, Anca Pantea
Bratu, Ovidiu Gabriel
Bacalbasa, Nicolae
Rus, Marius
Diaconu, Camelia Cristina
DIAGNOSTICS, 2020, 10 (07)
[26] Lipid peroxidation, cardiovascular risk factors and statin
Bayes, Beatriz
MEDICINA CLINICA, 2011, 136 (05): : 202 - 204
[27] Cardiovascular risk management in clinical practice: Time to change
Volpe M.
Erhardt L.R.W.
Williams B.
High Blood Pressure & Cardiovascular Prevention, 2008, 15 (1) : 9 - 16
[28] Clinical practice guideline for cardiovascular risk management in the Netherlands
Smulders, Y. M.
Burgers, J. S.
Scheltens, T.
van Hout, B. A.
Wiersma, T.
Simoons, M. L.
NETHERLANDS JOURNAL OF MEDICINE, 2008, 66 (04): : 169 - 174
[29] Economic and clinical implications of statins in cardiovascular risk management
Barry, M
PHARMACOECONOMICS, 2003, 21
[30] Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study
Steenhuis, Dennis
de Vos, Stijn
Bos, Jens
Hak, Eelko
CARDIOVASCULAR THERAPEUTICS, 2022, 2022

← 1 2 3 4 5 →